According to the Catalogue Of Somatic Mutations In Cancer, COSMIC, those mutations are observed in 8.75% of total mutated samples from kidney (Table 1); however, Zhang and colleagues have shown that 69 (25.9%) out of 226 samples from renal cancer patients exhibit p53 mutations [33]. This evidence concerns the gene TP53 and renal carcinoma.